Emma Reeve

Ms. Emma Reeve is an Independent Director at Cardurion Pharmaceuticals, Inc., an Independent Director at Whitehawk Therapeutics, Inc., an Independent Director at PTC Therapeutics, Inc. and an Associate at The Institute of Chartered Accountants in England & Wales.
She is on the Board of Directors at Cardurion Pharmaceuticals, Inc., Whitehawk Therapeutics, Inc., Aadi Subsidiary, Inc., Ribon Therapeutics, Inc., PTC Therapeutics, Inc. and Tufts Medical Center, Inc. Ms. Reeve was previously employed as a Chairman by Editas Medicine, Inc., a Chief Financial Officer, Treasurer & Senior VP by Constellation Pharmaceuticals, Inc., a Chief Financial Officer & Vice President by PAREXEL International Corp., a Head- Finance & Administration by Sandoz-Wander Pharma AG, a Head-Business Planning & Analysis by Novartis Vaccines & Diagnostics SAS, a Chief Financial Officer by Inotek Pharmaceuticals Corp., a Senior Director-Research Operations by Merck Research Laboratories Massachusetts LLC, a Chief Financial Officer by Aton Pharma, Inc., and an Assistant Controller by Bristol Myers Squibb Co. She also served on the board at Novitas Loans Ltd. She received her undergraduate degree from Imperial College London.